Performance of HIK Hikma Pharmaceuticals PLC | 8.4% in 12m
Compare HIK with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Hikma Pharmaceuticals PLC with its related Sector/Index XLV
Performance Duell HIK vs XLV
| TimeFrame | HIK | XLV |
|---|---|---|
| 1 Day | 1.82% | 0.40% |
| 1 Week | 1.55% | 0.69% |
| 1 Month | 5.21% | -1.27% |
| 3 Months | 4.58% | -1.44% |
| 6 Months | 11.5% | 11.14% |
| 12 Months | 8.40% | 7.58% |
| YTD | 12.4% | 2.26% |
| Rel. Perf. 1m | 0.55 | |
| Rel. Perf. 3m | 0.77 | |
| Rel. Perf. 6m | -0.96 | |
| Rel. Perf. 12m | 0.45 |
Is Hikma Pharmaceuticals PLC a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Hikma Pharmaceuticals PLC (LSE:HIK) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.92 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HIK as of May 2024 is 1795.22. This means that HIK is currently overvalued and has a potential downside of -8.41% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HIK as of May 2024 is 1795.22. This means that HIK is currently overvalued and has a potential downside of -8.41% (Sold with Premium).
Is HIK a buy, sell or hold?
Hikma Pharmaceuticals PLC has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 8.40%.
In compare to Health Care Sector SPDR Fund, HIK made 0.82% more over the last 12 months. Due to the inline performance, it is recommend to hold HIK.
In compare to Health Care Sector SPDR Fund, HIK made 0.82% more over the last 12 months. Due to the inline performance, it is recommend to hold HIK.
Values above 0%: HIK is performing better - Values below 0%: HIK is underperforming
Compare HIK with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.27% | 5.57% | -7.89% | -18.60% |
| US NASDAQ 100 | QQQ | -0.18% | 5.26% | -8.18% | -28.86% |
| US Dow Jones Industrial 30 | DIA | 0.34% | 5.26% | -3.45% | -9.19% |
| German DAX 40 | DBXD | 1.29% | 5.22% | -8.29% | -5.03% |
| UK FTSE 100 | ISFU | 0.74% | 1.61% | -2.43% | -0.35% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.35% | 1.81% | 9.64% | 19.57% |
| Hongkong Hang Seng | HSI | -3.13% | -3.62% | 12.48% | 22.51% |
| Japan Nikkei 225 | EXX7 | -1.07% | 7.34% | -4.23% | -11.29% |
| India NIFTY 50 | INDA | 1.85% | 4.54% | -6.99% | -18.34% |
| Brasil Bovespa | EWZ | -0.28% | 3.58% | 6.97% | -10.88% |
HIK Hikma Pharmaceuticals PLC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.13% | 6.69% | -9.76% | -32.28% |
| Consumer Discretionary | XLY | 1.66% | 4.67% | -1.01% | -14.71% |
| Consumer Staples | XLP | 1.43% | 3.07% | -0.39% | 7.16% |
| Energy | XLE | 4.76% | 10.08% | 0.72% | -11.91% |
| Financial | XLF | 0.79% | 6.41% | -11.48% | -20.90% |
| Health Care | XLV | 0.86% | 6.48% | 0.38% | 0.82% |
| Industrial | XLI | 1.12% | 6.53% | -11.91% | -18.31% |
| Materials | XLB | 1.77% | 8.12% | -4.58% | -6.99% |
| Real Estate | XLRE | 1.12% | 8.73% | 2.72% | 5.97% |
| Technology | XLK | -0.56% | 5.95% | -7.47% | -28.20% |
| Utilities | XLU | -0.94% | -0.31% | -1.90% | 5.36% |
| Aerospace & Defense | XAR | -1.65% | 2.47% | -6.86% | -17.68% |
| Biotech | XBI | -4.37% | 4.77% | -18.12% | 2.29% |
| Homebuilder | XHB | -0.73% | 6.80% | -28.78% | -43.86% |
| Retail | XRT | 0.07% | 5.73% | -9.96% | -14.79% |
Does Hikma Pharmaceuticals PLC outperform its market, is HIK a Sector Leader?
Yes, over the last 12 months Hikma Pharmaceuticals PLC (HIK) made 8.40%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.58%.
Over the last 3 months HIK made 4.58%, while XLV made -1.44%.
Yes, over the last 12 months Hikma Pharmaceuticals PLC (HIK) made 8.40%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.58%.
Over the last 3 months HIK made 4.58%, while XLV made -1.44%.
| Period | HIK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 5.21% | -1.27% | -0.36% |
| 3 Months | 4.58% | -1.44% | 4.90% |
| 12 Months | 8.40% | 7.58% | 27.00% |